President Trump’s re-election campaign is having trouble finding a theme song that conveys the correct message of the past almost-four years.
Some suggestions fell by the wayside for various reasons, including threatened suits from songwriters and artists.
Thus far Trump has been told not to use “Rockin’ in the Free World” (Neil Young); “It’s the End of the World” and “Everybody Hurts” (REM); ”Rolling in the Deep” (Adele); “Rocketman” (Elton John); “We Are The Champions” (Queen); “Here Comes the Sun” (Beatles); “We’re Not Gonna Take It” (Twisted Sister);
And, “Happy” (Pharrell Williams); “Don’t Stop the Music (Rihanna); “Photograph” (Nickleback); “You Can’t Get What You Want” (Rolling Stones); “Purple Rain” (Estate of Prince); “I Won’t Back Down” (Estate of Tom Petty); and “High Hopes” (Brandon Urie).
The songs that might be considered by the Trump campaign are “Who Let the Dogs Out?” (Baha Men); “I Like Big Butts” (Sir Mix A Lot); “Do You Really Want to Hurt Me” (Culture Club); “Broken” (Seether); “Bad Day” (Daniel Powter); “King of Pain” (The Police); “Hurts Like Hell” (Fluerie);
Research in the Context of a Pandemic H. Clifford Lane, M.D., and Anthony S. Fauci, M.D. (DR. FAUCI IS THE LITTLE FELLOW WHO KNOWS A LOT ABOUT INFECTIOUS DISEASE AS WELL AS FINESSE). In the RECOVERY trial, the benefit of the glucocorticoid dexamethasone for patients with Covid-19 who were receiving mechanical ventilation at the time of randomization was clearly shown. A 28-day mortality of 29.3% was reported for patients in the dexamethasone group as compared with 41.4% in the usual care group. In contrast, no benefit for dexamethasone was seen in patients not requiring oxygen at the time of randomization, with 28-day mortality of 17.8% and 14.0% for the dexamethasone group and the usual care group, respectively. For the heterogeneous group of patients receiving oxygen without invasive mechanical ventilation, mortality was 23.3% in the dexamethasone group and 26.2% in the usual care group. These findings, while limited to patients with Covid-19, provides clarity to an area of therapeutic controversy and probably will result in many lives saved. The use of dexamethasone already has been endorsed by several treatment-guideline panels, including that convened by the U.S. National Institutes of Health.2 (J. Harris: Improved survival in the intensively ventilated patients, but not in the less intensively treated patients. Perhaps patient selection made for differences in the groups?)